JASVIR KAILEY: Open Payments
NPI 1861946386 · MILWAUKEE, WI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,362 in 72 payments from 15 companies in 2025. Trend: 2023 $1,096 · 2024 $1,890 · 2025 $1,362
Food & beverage: $1,362
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $253 |
| PFIZER INC. | 10 | $181 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $174 |
| AstraZeneca Pharmaceuticals LP | 7 | $147 |
| Lilly USA, LLC | 9 | $130 |
| Phathom Pharmaceuticals, Inc. | 3 | $100 |
| Otsuka America Pharmaceutical, Inc. | 4 | $81 |
| Novo Nordisk Inc | 3 | $73 |
| Lundbeck LLC | 3 | $62 |
| Kowa Pharmaceuticals America, Inc. | 3 | $50 |
Products named: VRAYLAR, NURTEC ODT, CAPLYTA, REXULTI, MOUNJARO, AIRSUPRA, VOQUEZNA, Ozempic.
Industry payments across WI — which companies pay providers there.
